Drug resistance in fecal enterococci in Hong Kong

Journal of Infection and Chemotherapy

Volumn 10, Issue 6, 2004, Pages 326-330

  Boost, Maureen ^a   Lai, Lydia ^a   O'Donoghue, Margaret ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Antibiotic associated diarrhea; Community subjects; Enterococci; Vancomycin

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; LEVOFLOXACIN; NITROFURANTOIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TETRACYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; CULTURE MEDIUM; DIARRHEA; DRUG USE; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; FECES ANALYSIS; FEMALE; HONG KONG; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PUBLIC HOSPITAL; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 12444324503     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-004-0337-z     Document Type: Article

References (43)

1. Murray, BE. Vancomycin-resistant enterococci. Am J Med 1997;102:284-93.
2. Gordon S, Swenson JM, Hill BC, Pigott NE, Facklam RR, Cooksey RC, et al. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. J Clin Microbiol 1992;30:2373-78.
3. Linden PK, Miller CB. Vancomycin resistant enterococci: the clinical effect of a common nosocomial pathogen. Diagn Microbiol Infect Dis 1999;33:113-20.
4. Patterson JE, Sweeney AH, Simms M, Carley N, Mangi R, Sabetta J, et al. Analysis of 110 series enterococcal infections. Epidemiology, antibiotic susceptibility and outcome. Medicine (Baltimore) 1995;74:191-200.
5. Mundy LM, Sahm DF, Gilmore M. Relationships between enterococcal virulence and antimicrobial resistance. Clin Microbiol Rev 2000;13:513-22.
6. Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 1993;37:1563-71.
7. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev 2000;13:686-707.
8. Gold HS, Moellering RC. Antimicrobial drug resistance. N Engl J Med 1996;335:1445-53.
9. Uttley AHC, Collins CH, Naidoo J, George, RC, Vancomycin-resistant enterococci. Lancet 1988;1:57-8.
10. Leclerq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-61.
11. Frieden TR, Munsiff SS, Low DE, Willey BM, Williams G, Faur Y, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993;342:76-9.
12. Woodford N, Johnson AP, Morrison D. Current perspectives on glycopeptide resistance. Clin Microbiol Rev 1995;8:585-615.
13. National Nosocomial Infection Surveillance (NNIS) system report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999;27:520-32.
14. Ho PL, Ng TK, Yung RWH, Que TL, Yip EK, Tse CW, et al. Activity of linezolid against levofloxacin-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in Hong Kong. J Antimicrob Chemother 2001;48:587-95.
15. Ho, PL, The Hong Kong Intensive Care Unit Antimicrobial Resistance Study Group. Carriage of methicillin-resistant Staphylococcus aureus, ceftazidime-resistant Gram negative bacilli, and vancomycin-resistant enterococci before and after intensive care admission. Crit Care Med 2003;31:1175-82.
16. Moreno F, Grota P, Crisp C, Magnon K, Melcher GP, Jorgensen JH, et al. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis 1995;21:1234-7.
17. Tornieporth NG, Roberts RB, John J, Hafner A, Riley LW. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996;23:767-72.
18. Ostrowsky BE, Venkataraman L, D'Agata EM, Gold HS, DeGirolami PC, Samore MH. Vancomycin-resistant enterococci in intensive care units. Arch Intern Med 1999;159:1467-72.
19. Bonten MJ, Slaughter S, Ambergen AW, Hayden MK, van Voorhis J, Nathan C, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci. Arch Intern Med 1998;158:1227-32.
20. Luber AD, Jacobs RA, Jordan M, Guglielmo BJ, Relative importance of oral versus intravenous vancomycin exposure in the development of vancomycin-resistant enterococci. J Infect Dis 1996;173:1292-3.
21. Centers for Disease Control and Prevention. Recommendations for preventing spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995;16:105-13.
22. Montecalvo MA, de Lancestre H, Carraher M, Gedris C, Chung M, Van Horn K, et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1995;16:680-5.
23. Jordens JZ, Bates J, Griffiths DT. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 1994;34:515-28.
24. Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996;23:1234-9.
25. Bingen EH, Denamur E, Lambert-Zechovsky NY, Elion J. Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital. J Clin Microbiol 1991;29:1888-92.
26. Robredo, B, Singh, KV, Baquero, F, Murray, B, Torres, C. Vancomycin-resistant enterococci isolated from animals and food. Int J Food Microbiol 2000;54:197-204.
27. van den Bogaard, AE, Stobberingh, EE. Epidemiology of resistance to antibiotics: links between animals and humans. Int J Antimicrob Agents 2000;14:327-35.
28. Facklam RR, Sahm DF, Teixeira LM. Enterococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenovere FC, Yolken RH, editors. Manual of clinical microbiology. 7th ed. Washington DC: American Society for Microbiology: 1999. p. 297-305.
29. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th Ed. Approved Standard M7-A5. Wagne, PA: National Committee for Laboratory Standards: 2000.
30. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. 7th Ed. Approved Standard M2-A6. Wagne, PA: National Committee for Laboratory Standards; 2000.
31. Jones RN, Edson DC, CAP Microbiology Resource Committee of the College of American Pathologists. Antimicrobial susceptibility testing trends and accuracy in the United States. Arch Pathol Lab Med 1991;115:429-36.
32. Sahm DF, Torres C. Effects of medium and inoculum variations on screening for high level aminoglycoside levels in Enterococcus faecalis. J Clin Microbiol 1988;26:250-6.
33. Swenson JM, Ferraro, MJ, Sahm D, Clark NC, Culver D, Tenover FC, The National Committee for Clinical Laboratory Standards Working Group on Enterococci. Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci. J Clin Microbiol 1995;33:3008-18.
34. Nelson RR, McGregor KF, Brown AR, Amyes SG, Young H. Isolation and characterization of glycopeptide-resistant enterococci from hospitalized patients over a 30-month period. J Clin Microbiol 2000;38:2112-6.
35. Hacek DM, Bednarz P, Noskin GA, Zembower T, Peterson LR. Yield of vancomycin-resistant enterococci and multidrug resistant Enterobacteriaceae from stools submitted for Clostridium difficile testing compared to results from a focused surveillance program. J Clin Microbiol 2001;39:1152-4.
36. Garbutt JM, Littenberg B, Evanoff BA, Sahm D, Mundy LM. Enteric carriage of vancomycin-resistant Enterococcus faecium in patients tested for Clostridium difficile. Infect Control Hosp Epidemiol 1999;20:664-70.
37. Lautenbach E, Patel JB, Bilker WB, Fishman NO. Trends in antimicrobial susceptibility patterns among inpatient enterococcal isolates (1990 to 1999): implications for therapeutic options. Infect Control Hosp Epidemiol 2002;23:416-8.
38. Bonora MG, Bordin C, Bragagnolo L, Cirelli L, De Fatima M, Grossato A, et al. Molecular analysis of vanA enterococci isolated from humans and animals in northeastern Italy. Microb Drug Resist 2001;7:247-56.
39. Miyazaki S, Ishii Y, Olino A, Furuya N, Matsumoto T, Tateda K, et al. In-vitro activities of 11 antibiotics against vancomycin-resistant enterococci isolated in Japan. J Antimicrob Chemother 1999;44:415-20.
40. van der Bogaard AE, Willems R, London N, Top, J, Stobberingh EE. Antibiotic resistance of faecal enterococci in poultry, poultry farmers, and poultry slaughterers. J Antimicrob Chemother 2002:49:497-505.
41. D'Agata EM, Gautam S, Green WK, Tang YW. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis 2002;34:167-72.
42. Olofsson MB, Pornull KJ, Karnell A, Telander B, Svenungsson B, Fecal carriage of vancomycin- and ampicillin-resistant enterococci observed in Swedish adult patients with diarrhoea but not among healthy subjects. Scand J Infect Dis 2001;33:659-62.
43. Baran J Jr, Ramanathan J, Riederer KM, Khatib R. Stool colonization with vancomycin-resistant enterococci in healthcare workers and their households. Infect Control Hosp Epidemiol 2002;23:23-6.